Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal versus oral diclofenac after episiotomy repair
PACTR202509721616997Phase 4Completed
- Sponsor
- DR. TINU JOSHUA GANI
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diclofenac (2 arms), sponsored by DR. TINU JOSHUA GANI. Primary endpoint: Pain relief following episiotomy repair. Started Aug 2025; status: completed.
02
Drugs
diclofenac
Beyond the preview
Go deeper on PACTR202509721616997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509721616997.